Head-to-head · Cost-Efficiency Index
OlleveCare vs Transcarent
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
OlleveCare
Shoppers already confirmed in one of its 13 covered jurisdictions who don't mind booking before seeing a price.
Visit OlleveCareTranscarent
Cost-first shoppers who want not applicable -- only accessible through an employer or health plan, not individual consumers.
Visit TranscarentThe verdict
OlleveCare and Transcarent tie on the Cost-Efficiency Index at 43/100, so neither wins outright on the numbers. For most shoppers we'd start with OlleveCare (ranked #499, a hair above #504) — Shoppers already confirmed in one of its 13 covered jurisdictions who don't mind booking before seeing a price. But Transcarent is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs OlleveCare.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | OlleveCare | Transcarent |
|---|---|---|
| Cost-Efficiency Index | 43/100 | 43/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | 13 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #499 | #504 |
OlleveCare
43/100Where the value is
- Publishes a specific, checkable list of covered jurisdictions rather than a vague 'most states' claim
- Issues superbills so cash-pay patients can attempt insurance reimbursement, unlike many pure-compounding competitors
- States plainly that lab work 'may be required,' setting an expectation of clinical monitoring rather than a pure prescription mill
The tradeoffs
- No GLP-1 price is published anywhere on the public site — the fee only appears inside the booking calendar after starting the process
- Coverage is limited to 13 jurisdictions, notably narrower than most 50-state compounded-GLP-1 competitors
Transcarent
43/100Where the value is
- Backed by large-scale enterprise health infrastructure and employer/health-plan partnerships
- Weight Health program integrates behavioral, pharmacy, and surgical care rather than medication alone
The tradeoffs
- No direct-to-consumer purchase option or published price at all
- Requires employer or health plan sponsorship to access -- most readers cannot use this
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.